- Home
- GBIO vs TOPS Comparison
GBIO vs TOPS Comparison
Compare GBIO & TOPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- TOPS
- Stock Information
- Founded
- GBIO 2016
- TOPS 2000
- Country
- GBIO United States
- TOPS Greece
- Employees
- GBIO N/A
- TOPS N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- TOPS Marine Transportation
- Sector
- GBIO Health Care
- TOPS Consumer Discretionary
- Exchange
- GBIO Nasdaq
- TOPS Nasdaq
- Market Cap
- GBIO 35.2M
- TOPS 28.3M
- IPO Year
- GBIO 2020
- TOPS 2004
- Fundamental
- Price
- GBIO $0.51
- TOPS $5.92
- Analyst Decision
- GBIO Strong Buy
- TOPS
- Analyst Count
- GBIO 2
- TOPS 0
- Target Price
- GBIO $6.50
- TOPS N/A
- AVG Volume (30 Days)
- GBIO 386.8K
- TOPS 9.4K
- Earning Date
- GBIO 03-18-2025
- TOPS 03-28-2025
- Dividend Yield
- GBIO N/A
- TOPS N/A
- EPS Growth
- GBIO N/A
- TOPS N/A
- EPS
- GBIO N/A
- TOPS N/A
- Revenue
- GBIO $18,582,000.00
- TOPS $83,870,000.00
- Revenue This Year
- GBIO $212.74
- TOPS $7.10
- Revenue Next Year
- GBIO N/A
- TOPS $6.54
- P/E Ratio
- GBIO N/A
- TOPS N/A
- Revenue Growth
- GBIO 514.08
- TOPS 1.10
- 52 Week Low
- GBIO $0.47
- TOPS $5.30
- 52 Week High
- GBIO $4.65
- TOPS $14.50
- Technical
- Relative Strength Index (RSI)
- GBIO 31.86
- TOPS 41.57
- Support Level
- GBIO $0.47
- TOPS $5.72
- Resistance Level
- GBIO $0.62
- TOPS $6.06
- Average True Range (ATR)
- GBIO 0.05
- TOPS 0.21
- MACD
- GBIO 0.01
- TOPS 0.01
- Stochastic Oscillator
- GBIO 24.10
- TOPS 35.73
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The company focuses on the transportation of petroleum products (clean and dirty) and bulk liquid chemicals. The Company is an international provider of worldwide oil, petroleum products and chemical transportation services. It generates revenue from the Time Charter agreements.